N@N

CRH Medical introduces non surgical hemorroid removal to Gastroenterology Fellowship program

^{Published on 2009-06-29 09:31:04, Last Modified on 2009-06-29 09:31:51 - Market Wire}
 

 VANCOUVER, June 29 /CNW/ - CRH Medical Corporation (CRM:TSX-V) announced today that the University of South Alabama College of Medicine in Mobile Alabama has completed a training program involving its Teaching Faculty and Gastroenterology Fellows on the non surgical removal of hemorrhoids using the CRH O'Regan Banding Technology. Commenting on the incorporation of this training program into its Fellowship Program, University of South Alabama Professor of Medicine, Dr. Jack Di Palma said "This program enhances our training curriculum and enhances our Fellowship education program. I would encourage other Fellowship Programs to take advantage of it. Our Fellows enjoyed the training, and will continue to put these skills to good use as their careers progress." Dr Di Palma further stated "Hemorrhoids used to be a nuisance; we now have a proven treatment modality that benefits our patients as well as our practices." There are currently 162 Fellowship Programs operating in the US. CRH is making this same educational program available to each of these Fellowship Programs. The Company believes that a partnership between itself and gastroenterologists allow for an outstanding continuum of care for patients. About CRH Medical Corporation: CRH Medical Corporation specializes in the treatment of hemorrhoids utilizing its proven treatment protocol and patented proprietary technology. CRH's single use, disposable, hemorrhoid technology is safe and highly effective in treating hemorrhoid grades I - IV. CRH Medical employs two commercialization strategies: First, it operates Centers for Colorectal Health facilities in the United States specializing in the treatment of hemorrhoids and fissures, and colon cancer screening. In addition CRH distributes its hemorrhoid banding technology, treatment protocols, operational and marketing expertise as a complete, "turn key" package directly to its partner physicians. The Company's goal is to establish the CRH hemorrhoid technology as the standard for hemorrhoid treatment. About University of South Alabama: USA Gastroenterology is an academic division of the Department of Medicine whose mission is teaching, research, and patient care. The division is responsible for teaching gastrointestinal, nutritional, and hepatology physiology and pathophysiology to medical students, residents, and fellows, as well as to attending physicians for continuing education. Supervised consultation concerning digestive disorders is available throughout the Academic Health Center at USA Medical Center, Infirmary West, USA Children's and Women's Hospital, and their private practice located within the Digestive Health Center at Infirmary West. The information in this news release contains so-called "forward-looking" statements. These include statements regarding CRH Medical expectations, beliefs, intentions or strategies for the future, which may be indicated by words or phrases such as "anticipate", "expect", "intend", "plan", "will", "we believe", "CRH Medical believes", "management believes" and similar language. All forward-looking statements are based on CRH Medical current expectations and are subject to risks and uncertainties and to assumptions made. The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this release. 

For further information: Dean Linden, Corporate Communications, CRH Medical Corporation at (604) 633-1440 or [ ir@crhmedcorp.com ]; Additional information may also be found by visiting the Company's website at [ www.crhmedcorp.com ] or the SEDAR website at [ www.sedar.com ]